Does Liso-Cel Offer Long-Term Survival Benefits in R/R LBCL?

Published Date: 27 Jun 2026

Researchers report the 5-year survival outcomes with lisocabtagene maraleucel in heavily pretreated patients with relapsed or refractory LBCL in the TRANSCEND study.

Read Full News

Latest News

S4 Episode 6: Can Diet Improve Psoriasis Outcomes?

Many patients ask whether changing what they eat can help their psoriasis. Dr Joel Gelfand reviews the MEDIPSO trial and explains when a Mediterranean diet may meaningfully improve disease severity.

What Algorithms Cannot Heal: The Future of Rural Dermatology

Geographic barriers delay diagnoses, worsen outcomes, and increase morbidity from inflammatory skin disease and mortality from skin cancer, and patients often travel hours for specialty care.

Frailty Tied to Complications After Incontinence Surgery

Frailty is associated with complications and mortality within a year after stress urinary incontinence surgery in older men.

Guideline Update: Thyroid Disease in Pregnancy

Drs Kaniksha Desai and Angela Leung discuss the new guidelines for thyroid disease in preconception, pregnancy, and postpartum.

Starting Over: What Changing Practices Taught Me About Trust

Vaccine hesitancy and misinformation get the blame for declining patient trust, but Dr Kenny Lin argues a major factor is being overlooked: disappearing continuity of care.

Radiation Deserts Grow as Rural Radiation Sites Are Lost

More than 50 million Americans live in counties without a radiation oncology practice site as rural and community-based centers disappear at higher rates.

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Latest News

Many patients ask whether changing what they eat can help their psoriasis. Dr Joel Gelfand reviews the MEDIPSO trial and explains when a Mediterranean diet may meaningfully improve disease severity.
HTTP error: 503

Frailty is associated with complications and mortality within a year after stress urinary incontinence surgery in older men.

Drs Kaniksha Desai and Angela Leung discuss the new guidelines for thyroid disease in preconception, pregnancy, and postpartum.
HTTP error: 503

More than 50 million Americans live in counties without a radiation oncology practice site as rural and community-based centers disappear at higher rates.

News All Time

Both Sides of the Bars: Jail Reform as Mental Health Policy

Jails have become de facto psychiatric institutions. Dr Temitope Ogundare explains why psychiatrists should help prevent incarceration — not just treat its consequences.

The Challenge With Health Data Is Using It Well

An international survey finds physicians are ready to use wearable health data. The bigger challenge is building the systems to turn that information into better care.
HTTP error: 503

Should Age Trigger Physician Screening? Many Doctors Say No

A Medscape commentary asks whether older physicians should be tested for competence. Readers answer with a question of their own: Why single out age?
HTTP error: 503HTTP error: 503

Indigenous Canadians Face Cancer Survival Inequalities

Breast, colon, and cervical cancer incidence and mortality have improved for First Nations patients, but survival is significantly lower than that of other Ontario residents.
HTTP error: 503

Medicaid Patients Half as Likely to Get Menopause Meds

Women with private insurance were twice as likely to report a history of hormone therapy for menopause than those covered by Medicaid.

At-Home Lecanemab: ‘Encouraging’ First Data

Early real-world data suggest that weekly at-home subcutaneous lecanemab may offer a feasible alternative to ongoing IV maintenance treatment for early Alzheimer’s disease.
HTTP error: 503HTTP error: 503

Health Data Platform Connects Hospitals Across Provinces

The VITAL system collects near real-time hospital data with the aim of optimizing healthcare delivery, research, and innovation while protecting privacy.

Blood Test Flags Gynaecologic Cancer Risk in NHS Trial

A blood test correctly flags 99% of gynaecologic cancers as high risk in the largest NHS AI triage trial yet.
HTTP error: 503HTTP error: 503

Recommended News For You

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging

Using MRD Status to Deescalate Multiple Myeloma Therapy

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Scientists develop scans that light up aggressive cancer tumors for better treatment

FDA Approves Sickle Cell Gene Therapy for Young Kids

Prostate Cancer Treatment Associated With Long-Term Complications

Recommended Articles For You

Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology 

An Introduction To The CA 15-3 Tumor Marker Test For Cancer Patients 

Clinical Perspectives in Oncology for Better Care 

Strategic Practices in Oncology for Specialists 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mental health risk persists years after cancer diagnosis

2.

Breast cancer prevention: How nurse practitioners and physician assistants can help

3.

For treatment, the majority of cancer patients choose complementary therapies.

4.

Cancer mortality continuing to decline, says report

5.

Doctors say lung cancer is still the deadliest cancer, but hope is growing

1.

Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success

2.

Bone Marrow Microenvironment Biomarkers in Hematologic Health

3.

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells

4.

HKDC1 Protein: An Emerging Therapeutic Target in Colon Cancer

5.

The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

5.

Efficient Management of First line ALK-rearranged NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot